v3.25.2
Condensed Statement of Changes in Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Total
Public Stock Offering
At The Market Offering
Common Stock
Common Stock
Public Stock Offering
Common Stock
At The Market Offering
Additional Paid-in Capital
Additional Paid-in Capital
Public Stock Offering
Additional Paid-in Capital
At The Market Offering
Accumulated Deficit
Beginning balance at Dec. 31, 2023 $ 15,937     $ 3     $ 52,759     $ (36,825)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Stock based compensation expense 2,247           2,247      
Sale of Common Stock, net of issuance costs     $ 76           $ 76  
Stock issuance upon exercise of stock options 8           8      
Net loss (9,562)                 (9,562)
Ending balance (in shares) at Jun. 30, 2024       26,562,111            
Ending balance at Jun. 30, 2024 8,706     $ 3     55,090     (46,387)
Beginning balance (in shares) at Mar. 31, 2024       26,329,032            
Beginning balance at Mar. 31, 2024 12,538     $ 3     53,966     (41,431)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Stock based compensation expense 1,040           1,040      
Sale of Common Stock, net of issuance costs (in shares)           50,000        
Sale of Common Stock, net of issuance costs     76           76  
Stock issuance upon exercise of stock options (in shares)       5,252            
Stock issuance upon exercise of stock options 8           8      
Stock issuance upon vesting of restricted stock units (in shares)       177,827            
Net loss (4,956)                 (4,956)
Ending balance (in shares) at Jun. 30, 2024       26,562,111            
Ending balance at Jun. 30, 2024 $ 8,706     $ 3     55,090     (46,387)
Beginning balance (in shares) at Dec. 31, 2024 26,960,901     26,960,901            
Beginning balance at Dec. 31, 2024 $ 1,654     $ 3     57,924     (56,273)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Stock based compensation expense $ 2,286           2,286      
Sale of Common Stock, net of issuance costs (in shares)         6,746,386 284,338        
Sale of Common Stock, net of issuance costs   $ 10,250 450     $ 1   $ 10,250 449  
Stock issuance upon exercise of stock options (in shares) 60,259     28,715            
Net loss $ (10,458)                 (10,458)
Ending balance (in shares) at Jun. 30, 2025 34,020,340     34,020,340            
Ending balance at Jun. 30, 2025 $ 4,182     $ 4     70,909     (66,731)
Beginning balance (in shares) at Mar. 31, 2025       33,734,548            
Beginning balance at Mar. 31, 2025 7,529     $ 3     69,283     (61,757)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Stock based compensation expense 1,177           1,177      
Sale of Common Stock, net of issuance costs (in shares)           284,338        
Sale of Common Stock, net of issuance costs     $ 450     $ 1     $ 449  
Stock issuance upon exercise of stock options (in shares)       1,454            
Net loss $ (4,974)                 (4,974)
Ending balance (in shares) at Jun. 30, 2025 34,020,340     34,020,340            
Ending balance at Jun. 30, 2025 $ 4,182     $ 4     $ 70,909     $ (66,731)